{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:02:46Z","timestamp":1778875366593,"version":"3.51.4"},"reference-count":32,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2000,7,1]]},"abstract":"<jats:p> PURPOSE: To study the clinicobiologic significance of acquired 11q deletions involving the ataxia teleangiectasia locus (ATM+\/\u2212) in B-cell non-Hodgkin\u2019s lymphomas (NHL). <\/jats:p><jats:p> PATIENTS AND METHODS: Fifty-three indolent lymphomas and 82 aggressive lymphomas were studied by conventional cytogenetic analysis and by fluorescence in situ hybridization using an 11q22\u201323 probe recognizing ATM sequences. Pertinent clinical data were collected. <\/jats:p><jats:p> RESULTS: A hemizygous ATM deletion was seen in 44% to 88% of the interphase cells in 15 cases (11.1%); four patients had an indolent lymphoma (follicular center cell lymphoma), and 11 patients had an aggressive lymphoma (five mantle-cell lymphomas [MCLs] and six diffuse large-cell lymphomas). Dual-color hybridization studies showed ATM deletion to be possibly a secondary aberration in three patients with MCL. Ten out of 15 ATM+\/\u2212 patients had a complex karyotype, 11 out of 15 had more than 90% abnormal metaphases (AA karyotype status), and +12, 13q14 deletion, and 17p13 deletion were seen in seven, four, and five cases, respectively. Patients with ATM+\/\u2212 more frequently had a complex karyotype (P = .01) and the AA karyotype (P = .04) compared with patients without ATM+\/\u2212. With the exception of a poor performance status (P = .001), no correlation was found between ATM+\/\u2212, initial clinical variables, and complete remission rate; whereas a highly significant association was found with shorter survival (P &lt; .0001). This cytogenetic lesion maintained its prognostic importance in multivariate analysis (P = .0004), along with performance status (P = .0006), serum lactate dehydrogenase level (P = .03), splenomegaly (P = .01), and histologic grade (P = .03). When analyzing indolent lymphomas and aggressive lymphomas separately, ATM+\/\u2212 maintained its prognostic importance as an independent variable in both histologic groups (P = .0001 and P = .016, respectively). <\/jats:p><jats:p> CONCLUSION: Though possibly not representing a primary genetic lesion in the majority of cases, the acquired ATM+\/\u2212 status has clinicobiologic importance in NHL, possibly representing a major cytogenetic determinant of outcome. <\/jats:p>","DOI":"10.1200\/jco.2000.18.13.2607","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T09:08:21Z","timestamp":1487927301000},"page":"2607-2614","source":"Crossref","is-referenced-by-count":35,"title":["Acquired Chromosome 11q Deletion Involving the Ataxia Teleangiectasia Locus in B-Cell Non-Hodgkin\u2019s Lymphoma: Correlation With Clinicobiologic Features"],"prefix":"10.1200","volume":"18","author":[{"given":"Antonio","family":"Cuneo","sequence":"first","affiliation":[{"name":"From the Dipartimento di Scienze Biomediche e Terapie AvanzateSezione di Ematologia, and Dipartimento di Medicina Sperimentale e Diagnostica, Sezione di Microbiologia, University of Ferrara, Ferrara, and Istituto Dermopatico dell\u2019Immacolata, IRCCS, Roma, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato","family":"Bigoni","sequence":"additional","affiliation":[{"name":"From the Dipartimento di Scienze Biomediche e Terapie AvanzateSezione di Ematologia, and Dipartimento di Medicina Sperimentale e Diagnostica, Sezione di Microbiologia, University of Ferrara, Ferrara, and Istituto Dermopatico dell\u2019Immacolata, IRCCS, Roma, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian Matteo","family":"Rigolin","sequence":"additional","affiliation":[{"name":"From the Dipartimento di Scienze Biomediche e Terapie AvanzateSezione di Ematologia, and Dipartimento di Medicina Sperimentale e Diagnostica, Sezione di Microbiologia, University of Ferrara, Ferrara, and Istituto Dermopatico dell\u2019Immacolata, IRCCS, Roma, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Grazia","family":"Roberti","sequence":"additional","affiliation":[{"name":"From the Dipartimento di Scienze Biomediche e Terapie AvanzateSezione di Ematologia, and Dipartimento di Medicina Sperimentale e Diagnostica, Sezione di Microbiologia, University of Ferrara, Ferrara, and Istituto Dermopatico dell\u2019Immacolata, IRCCS, Roma, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Milani","sequence":"additional","affiliation":[{"name":"From the Dipartimento di Scienze Biomediche e Terapie AvanzateSezione di Ematologia, and Dipartimento di Medicina Sperimentale e Diagnostica, Sezione di Microbiologia, University of Ferrara, Ferrara, and Istituto Dermopatico dell\u2019Immacolata, IRCCS, Roma, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Bardi","sequence":"additional","affiliation":[{"name":"From the Dipartimento di Scienze Biomediche e Terapie AvanzateSezione di Ematologia, and Dipartimento di Medicina Sperimentale e Diagnostica, Sezione di Microbiologia, University of Ferrara, Ferrara, and Istituto Dermopatico dell\u2019Immacolata, IRCCS, Roma, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Minotto","sequence":"additional","affiliation":[{"name":"From the Dipartimento di Scienze Biomediche e Terapie AvanzateSezione di Ematologia, and Dipartimento di Medicina Sperimentale e Diagnostica, Sezione di Microbiologia, University of Ferrara, Ferrara, and Istituto Dermopatico dell\u2019Immacolata, IRCCS, Roma, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Agostini","sequence":"additional","affiliation":[{"name":"From the Dipartimento di Scienze Biomediche e Terapie AvanzateSezione di Ematologia, and Dipartimento di Medicina Sperimentale e Diagnostica, Sezione di Microbiologia, University of Ferrara, Ferrara, and Istituto Dermopatico dell\u2019Immacolata, IRCCS, Roma, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiano","family":"De Angeli","sequence":"additional","affiliation":[{"name":"From the Dipartimento di Scienze Biomediche e Terapie AvanzateSezione di Ematologia, and Dipartimento di Medicina Sperimentale e Diagnostica, Sezione di Microbiologia, University of Ferrara, Ferrara, and Istituto Dermopatico dell\u2019Immacolata, IRCCS, Roma, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Grazia","family":"Narducci","sequence":"additional","affiliation":[{"name":"From the Dipartimento di Scienze Biomediche e Terapie AvanzateSezione di Ematologia, and Dipartimento di Medicina Sperimentale e Diagnostica, Sezione di Microbiologia, University of Ferrara, Ferrara, and Istituto Dermopatico dell\u2019Immacolata, IRCCS, Roma, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Sabbioni","sequence":"additional","affiliation":[{"name":"From the Dipartimento di Scienze Biomediche e Terapie AvanzateSezione di Ematologia, and Dipartimento di Medicina Sperimentale e Diagnostica, Sezione di Microbiologia, University of Ferrara, Ferrara, and Istituto Dermopatico dell\u2019Immacolata, IRCCS, Roma, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giandomenico","family":"Russo","sequence":"additional","affiliation":[{"name":"From the Dipartimento di Scienze Biomediche e Terapie AvanzateSezione di Ematologia, and Dipartimento di Medicina Sperimentale e Diagnostica, Sezione di Microbiologia, University of Ferrara, Ferrara, and Istituto Dermopatico dell\u2019Immacolata, IRCCS, Roma, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Negrini","sequence":"additional","affiliation":[{"name":"From the Dipartimento di Scienze Biomediche e Terapie AvanzateSezione di Ematologia, and Dipartimento di Medicina Sperimentale e Diagnostica, Sezione di Microbiologia, University of Ferrara, Ferrara, and Istituto Dermopatico dell\u2019Immacolata, IRCCS, Roma, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluigi","family":"Castoldi","sequence":"additional","affiliation":[{"name":"From the Dipartimento di Scienze Biomediche e Terapie AvanzateSezione di Ematologia, and Dipartimento di Medicina Sperimentale e Diagnostica, Sezione di Microbiologia, University of Ferrara, Ferrara, and Istituto Dermopatico dell\u2019Immacolata, IRCCS, Roma, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"R1-0344","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1992.tb08209.x"},{"key":"R2-0344","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.7.2516"},{"key":"R3-0344","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.21.11837"},{"key":"R4-0344","doi-asserted-by":"publisher","DOI":"10.1126\/science.7792600"},{"key":"R5-0344","doi-asserted-by":"publisher","DOI":"10.1038\/ng0897-397"},{"key":"R6-0344","doi-asserted-by":"publisher","DOI":"10.1038\/nm1097-1155"},{"key":"R7-0344","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.2.423.bloodjournal872423"},{"key":"R8-0344","unstructured":"Fegan  C,  Robinson  H,  Thompson  P, et al:  Karyotypic evolution in CLL.  Leukemia 9:2003,1995-2008,"},{"key":"R9-0344","doi-asserted-by":"publisher","DOI":"10.1038\/ng0997-96"},{"key":"R10-0344","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)10117-4"},{"key":"R11-0344","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.2.748"},{"key":"R12-0344","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.5.1361.1361"},{"key":"R13-0344","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.1.35"},{"key":"R14-0344","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V93.4.1372"},{"key":"R15-0344","unstructured":"Cuneo  A,  Bigoni  R,  Rigolin  GM, et al:  13q14 deletion in non-Hodgkin\u2019s lymphoma:  Correlation with clinicopathological features. Haematologica 84:589,1999-593,"},{"key":"R16-0344","unstructured":"Rasio  D,  Negrini  M,  Croce  CM:  Genomic organization of the ATM locus involved in ataxia-telangiectasia.  Cancer Res 55:6053,1995-6057,"},{"key":"R17-0344","unstructured":"Cuneo  A,  Bigoni  R,  Negrini  M, et al:  Cytogenetic and interphase cytogenetic characterization of atypical chronic lymphocytic leukemia carrying BCL1 translocation.  Cancer Res 57:1144,1997-1150,"},{"key":"R18-0344","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.6.2358.bloodjournal8662358"},{"key":"R19-0344","unstructured":"Croce  CM:  Molecular biology of lymphomas.  Semin Oncol 20:31,1993-46,   (suppl 5)"},{"key":"R20-0344","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.4.1043.1043"},{"key":"R21-0344","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V77.7.1508.1508"},{"key":"R22-0344","unstructured":"Dreyling  MH,  Bullinger  L,  Ott  G, et al:  Alterations of the cyclin D1\/p16-pRB pathway in mantle cell lymphoma.  Cancer Res 57:4608,1997-4614,"},{"key":"R23-0344","doi-asserted-by":"crossref","unstructured":"Offitt  K,  Gaidano  G,  Filippa  DA, et al:  6q deletions define distinct clinico-pathologic subsets of non-Hodgkin\u2019s lymphoma.  Blood 82:2157,1994-2162,","DOI":"10.1182\/blood.V82.7.2157.bloodjournal8272157"},{"key":"R24-0344","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.9.3262"},{"key":"R25-0344","unstructured":"Negrini  M,  Rasio  D,  Hampton  GM, et al:  Definition and refinement of chromosome 11 regions of LOH in breast cancer:  Identification of a new region at 11q23-24. Cancer Res 55:3003,1995-3007,"},{"key":"R26-0344","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.3143131.x"},{"key":"R27-0344","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V75.9.1841.1841"},{"key":"R28-0344","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V82.7.1994.1994"},{"key":"R29-0344","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(89)80692-8"},{"key":"R30-0344","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-108-1-14"},{"key":"R31-0344","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309303291402"},{"key":"R32-0344","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/110.3.347"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2000.18.13.2607","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T21:59:58Z","timestamp":1653515998000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2000.18.13.2607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7,1]]},"references-count":32,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2000,7,1]]}},"alternative-id":["10.1200\/JCO.2000.18.13.2607"],"URL":"https:\/\/doi.org\/10.1200\/jco.2000.18.13.2607","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,7,1]]}}}